RhumbLine Advisers’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-37,751
| Closed | -$5.29M | – | 2984 |
|
|
2018
Q4 | $5.29M | Buy |
37,751
+13,524
| +56% | +$1.89M | 0.01% | 1075 |
|
|
2018
Q3 | $4.14M | Sell |
24,227
-1,424
| -6% | -$243K | 0.01% | 1230 |
|
|
2018
Q2 | $4.45M | Buy |
25,651
+4,286
| +20% | +$744K | 0.01% | 1180 |
|
|
2018
Q1 | $2.47M | Sell |
21,365
-708
| -3% | -$81.7K | 0.01% | 1487 |
|
|
2017
Q4 | $1.86M | Sell |
22,073
-3,161
| -13% | -$266K | ﹤0.01% | 1664 |
|
|
2017
Q3 | $2.33M | Buy |
25,234
+2,608
| +12% | +$240K | 0.01% | 1519 |
|
|
2017
Q2 | $1.81M | Buy |
22,626
+5,260
| +30% | +$422K | ﹤0.01% | 1636 |
|
|
2017
Q1 | $731K | Buy |
17,366
+3,118
| +22% | +$131K | ﹤0.01% | 2075 |
|
|
2016
Q4 | $458K | Buy |
14,248
+1,674
| +13% | +$53.8K | ﹤0.01% | 2275 |
|
|
2016
Q3 | $329K | Buy |
12,574
+875
| +7% | +$22.9K | ﹤0.01% | 2430 |
|
|
2016
Q2 | $271K | Sell |
11,699
-958
| -8% | -$22.2K | ﹤0.01% | 2586 |
|
|
2016
Q1 | $346K | Buy |
12,657
+2,185
| +21% | +$59.7K | ﹤0.01% | 2453 |
|
|
2015
Q4 | $298K | Buy |
+10,472
| New | +$298K | ﹤0.01% | 2587 |
|